EBITDAF up 10.4% as NPAT fell 85.7% on prior-year disposal gain

EBITDAF rose 10.4% to $783M on higher customer sales, higher generation volumes and positive wholesale trading. Reported NPAT fell 85.7% to $95M, but the FY22 base of $664M included a $213M after-tax discontinued-operation gain from selling the Australian business plus large favourable hedge fair-value movements. Stripping those out, the company reports underlying NPAT up 35% to $315M.

Revenue declined 13.0% to $3,222M, largely on the absence of the divested Australian segment ($209M in FY22) and a sharply different wholesale revenue mix. Operating cash flow rose 10.4% to $509M, but capex more than doubled to $316M and net debt increased from $800M to $1,024M, lifting net debt to EBITDAF from 1.1x to 1.3x. The Board declared a 11.9 cps final dividend, taking the full-year ordinary dividend to 17.9 cps versus 17.4 cps.

• PBT fell 79.8% and NPAT fell 85.7%, but the PBT-versus-NPAT growth gap of just 5.9pp shows tax is not the distortion — the prior-year disposal gain and hedge fair-value swings are. EBITDAF up 10.4% and operating cash flow up 10.4% give a coherent picture of an operating result that genuinely improved. This matters because anyone anchoring on the headline NPAT collapse will materially misread the year.

• Capital intensity has stepped up sharply. Capex rose 124% to $316M (9.8% of revenue versus 3.8% prior), cash balances fell $151M to $212M, and gross borrowings rose to $1,236M. Leverage moved from 1.1x to 1.3x EBITDAF. This matters because the investment cycle is accelerating ahead of the associated EBITDAF and the buffer between cash generation and capital commitments has narrowed.

• Second-half NPAT swung negative. HY23 NPAT was $201M, so the implied H2 NPAT is a $106M loss even though implied H2 EBITDAF of $358M was only modestly below H1's $425M. This matters because it points to large non-cash hedge revaluations and other accounting items in H2 rather than an operating trading deterioration.

The seasonality shape is also distorted: HY23 carried 47.5% of full-year revenue and 54.3% of full-year EBITDAF, but contributed more than the entire reported NPAT, which is a signal about H2 non-cash items rather than H2 trading collapse.

What the release does support is that the gentailer's operating engine — customer volumes, generation and wholesale trading — is running ahead of prior year. What it does not support is any read on the durability of the H2 hedge-driven NPAT swing, because forward fair-value movements are not predictable from this disclosure.

Payout ratio versus pre-lease FCF is 73.3% based on the source-backed deterministic derivation.

The reported NPAT, however, is not analytically meaningful as a standalone earnings figure this year. Payout against reported NPAT computes at 483.8%, ROE prints at 1.6% (versus 12.0%), and FCF-to-NPAT runs at 607.4% — all three are symptoms of the prior-year disposal gain and current-year hedge mark-to-market depressing the denominator, not of dividend overreach. The genuine quality concerns sit on the balance sheet: capex intensity has nearly tripled as a share of revenue, cash holdings dropped 41.6%, and leverage has moved from 1.1x to 1.3x. None is alarming in isolation, but together they reduce financial flexibility relative to a year ago.

This briefing cannot assess the underlying generation, hydrology, customer-volume and forward hedge-book detail needed to translate the operating improvement into a forward EBITDAF view.